Bio techne Corp reported Revenue growth of 1.06% year on year in the fourth quarter 2025, to $ 321.19 millions, this is lower than Bio Techne Corp's recent average Revenue increase of 10.41%.
Looking into fourth quarter 2025 results within Biotechnology & Pharmaceuticals industry 43 other companies have achieved higher Revenue growth. While Bio Techne Corp' s Revenue increase of 1.06% ranks overall at the positon no. 2684 in the fourth quarter 2025.
Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025
Bio Techne's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
33.65 %
2.7 %
-23.88 %
(Sep 30 2011)
TECH's IV. Quarter Q/Q Revenue Comment
Bio techne Corp achieved in the IV. Quarter 2025 above company average sequential Revenue growth of 3.18%, to $ 321.19 millions, from $311.29 millions in the third quarter.
Within Biotechnology & Pharmaceuticals industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Bio Techne's Revenue growth quarter on quarter, overall rank is 1300.
Bio techne Corp achieved in the IV. Quarter 2025 above company average sequential Revenue growth of 3.18%, to $ 321.19 millions, from $311.29 millions in the third quarter.
Within Biotechnology & Pharmaceuticals industry 25 other companies have achieved higher Revenue quarter on quarter growth. While Bio Techne's Revenue growth quarter on quarter, overall rank is 1300.
Bio Techne's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 1,213.87
$ 1,210.49
$ 1,214.76
$ 1,216.37
$ 1,219.27
Y / Y Revenue Growth (TTM)
-0.44 %
0.24 %
1.62 %
3.86 %
5.26 %
Year on Year Revenue Growth Overall
Ranking
# 2029
# 1335
# 196
# 1395
# 1522
Seqeuential Revenue Change (TTM)
0.28 %
-0.35 %
-0.13 %
-0.24 %
0.97 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2471
# 1585
# 215
# 2292
# 1709
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Bio Techne reported a decrease in Revenue by -0.44% year on year, to $1,214 millions, compare to the 0.24% growth at Mar 31 2026.
In the Healthcare sector 305 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1335 to 2029.
For the 12 months ended Jun 30 2026 Bio Techne reported a decrease in Revenue by -0.44% year on year, to $1,214 millions, compare to the 0.24% growth at Mar 31 2026.
In the Healthcare sector 305 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1335 to 2029.
About Bio Techne Revenue Growth Rates (TECH), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
1.66%